重新认识胰腺癌手术治疗从解剖学向生物学的转变。 - Suppr

Suppr

超能文献

REDISCOVER the change in surgical management of pancreatic cancer from anatomy to biology.

作者信息

Ventin Marco, Ferrone Cristina R

机构信息

Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

出版信息

Updates Surg. 2024 Sep;76(5):1569-1571. doi: 10.1007/s13304-024-01956-7. Epub 2024 Aug 16.

DOI:10.1007/s13304-024-01956-7

PMID:39150628

Abstract

摘要

相似文献

REDISCOVER the change in surgical management of pancreatic cancer from anatomy to biology.

Updates Surg. 2024 Sep;76(5):1569-1571. doi: 10.1007/s13304-024-01956-7. Epub 2024 Aug 16.

REDISCOVER guidelines for borderline-resectable and locally advanced pancreatic cancer: management algorithm, unanswered questions, and future perspectives.

Updates Surg. 2024 Sep;76(5):1573-1591. doi: 10.1007/s13304-024-01860-0. Epub 2024 Apr 29.

REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer.

Ann Surg. 2024 Jul 1;280(1):56-65. doi: 10.1097/SLA.0000000000006248. Epub 2024 Feb 26.

Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study.

BMC Cancer. 2019 Jul 9;19(1):675. doi: 10.1186/s12885-019-5889-5.

Synoptic CT scan reporting of pancreatic adenocarcinoma to align with international consensus guidelines on surgical resectability: a Victorian pilot.

ANZ J Surg. 2022 Oct;92(10):2565-2570. doi: 10.1111/ans.17999. Epub 2022 Aug 24.

A patient-centered, multidisciplinary approach to treating borderline resectable pancreatic adenocarcinoma.

Chin Clin Oncol. 2022 Dec;11(6):45. doi: 10.21037/cco-22-86. Epub 2022 Nov 29.

Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial.

BMC Cancer. 2019 Oct 22;19(1):979. doi: 10.1186/s12885-019-6148-5.

Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection.

Eur Radiol. 2018 Oct;28(10):4265-4273. doi: 10.1007/s00330-018-5410-6. Epub 2018 Apr 20.

Advances in the Surgical Management of Resectable and Borderline Resectable Pancreas Cancer.

Surg Oncol Clin N Am. 2016 Apr;25(2):287-310. doi: 10.1016/j.soc.2015.11.008. Epub 2016 Feb 17.

High-resolution pancreatic computed tomography for assessing pancreatic ductal adenocarcinoma resectability: a multicenter prospective study.

Eur Radiol. 2023 Sep;33(9):5965-5975. doi: 10.1007/s00330-023-09584-2. Epub 2023 Mar 29.

引用本文的文献

Real-World Evidence of Porto-Mesenteric Vein Resections with Pancreatectomy and the Development of Predictive Clinical Nomograms for Postoperative Outcomes-An Analysis of 389 Cases: The "Porto-Mesenteric Vein Resection-Indian MulticentrE" (PRIME) Study.

Ann Surg Oncol. 2025 Jul 5. doi: 10.1245/s10434-025-17702-1.

本文引用的文献

Correction: Intraperitoneal prophylactic drain after pancreaticoduodenectomy: an Italian survey.

Updates Surg. 2024 Oct;76(6):2501. doi: 10.1007/s13304-024-01967-4.

REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer.

Ann Surg. 2024 Jul 1;280(1):56-65. doi: 10.1097/SLA.0000000000006248. Epub 2024 Feb 26.

Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective cohort study (NORPACT-2).

BJS Open. 2023 Nov 1;7(6). doi: 10.1093/bjsopen/zrad137.

Ca 125 is an independent prognostic marker in resected pancreatic cancer of the head of the pancreas.

Updates Surg. 2023 Sep;75(6):1481-1496. doi: 10.1007/s13304-023-01587-4. Epub 2023 Aug 3.

Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial.

JAMA Oncol. 2022 Sep 1;8(9):1263-1270. doi: 10.1001/jamaoncol.2022.2319.

Neoadjuvant Therapy for Resectable Pancreatic Cancer: An Evolving Paradigm Shift.

Front Oncol. 2019 Oct 17;9:1085. doi: 10.3389/fonc.2019.01085. eCollection 2019.

Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial.

JAMA Oncol. 2018 Jul 1;4(7):963-969. doi: 10.1001/jamaoncol.2018.0329.

Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer.

Ann Surg. 2015 Jan;261(1):12-7. doi: 10.1097/SLA.0000000000000867.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验